Section 32

Section 32

S32 is a venture capital firm investing at the frontiers of technology, healthcare and the life sciences with focus areas including biotechnology, therapeutics, advanced diagnostics, precision medicine, software, cybersecurity, machine learning, and artificial intelligence. The firm’s goal is to improve the human condition by accelerating the discovery, development, adoption and distribution of important technologies and life saving medicines.

Key Info

Team